Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics granted inducement awards to four new employees, consisting of options to purchase an aggregate of 115,250 shares of common stock. The options have an exercise price equal to the closing price on the grant dates of August 3 and August 6, 2026, and will vest over a four-year period with a one-year cliff.
Key figures
- Vesting period years
- 4
- Aggregate options granted
- 115250
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.